State Street’s Cardio Diagnostics CDIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CDIO
XT
TRCT
State Street's CDIO Position: Q2 2026 in Review
State Street opened a new position in Cardio Diagnostics (CDIO) in Q2 2026: 10,099 shares worth $22.1K. The stake represents ﹤0.01% of the portfolio and ranks #4127 among its holdings. This is a return to the name: State Street previously reported a position in CDIO as recently as Q1 2025.
State Street first reported a position in CDIO in Q1 2023 and has held it in 10 quarters since. The position peaked at $163K in Q1 2023. 17 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.
- State Street held 10,099 shares of Cardio Diagnostics worth $22.1K as of Q2 2026.
- Cardio Diagnostics was a new State Street position in Q2 2026.
- Cardio Diagnostics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4127 holding.
- State Street first reported a position in Cardio Diagnostics in Q1 2023 and has held it in 10 quarters since.
- State Street's Cardio Diagnostics position peaked at $163K in Q1 2023.
- 17 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.